Background. Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry accurately identifies both selected bacteria and bacteria in select clinical situations. It has not been evaluated for routine use in the clinic.
plete identification is routinely achieved within hours in the best cases or days for fastidious organisms. Such conventional, time-consuming procedures hamper proper treatment of patients with respect to antibiotic and supportive treatments. Rapid and accurate identification of routinely encountered bacterial species is therefore warranted to improve the care of patients with infectious diseases.
Bacterial identification based on peptidic spectra obtained by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry was proposed 130 years ago [2] [3] [4] . It has only recently been used as a rapid, inexpensive, and accurate method for Increasing number of publications related to matrix-assisted laser desorption ionization time-of-flight mass spectrometry applications in medical microbiology. Applications include the identification of isolates, the identification of specific antibiotic-resistance profile, and typing of isolates.
identifying isolates that belong to certain bacterial phyla ( Figure  1 ). It has also proved useful for identifying bacteria isolated in selected clinical situations, such as cystic fibrosis [5] . However, previous studies did not evaluate the effectiveness of MALDI-TOF mass spectrometry identification for routine use in the clinics, because they included bacterial isolates gathered from past collections and grown in conditions selected for the study [6] or incorporated isolates subcultured in selected growth conditions prior to MALDI-TOF mass spectrometry analysis [7] .
We evaluated the performance and cost-effectiveness of MALDI-TOF mass spectrometry for the routine identification of bacteria, regardless of their phylogeny and relation to any specific clinical situation.
MATERIALS AND METHODS
Bacterial isolates. All isolates recovered from blood, cerebrospinal fluid, pus, biopsy, respiratory tract, wound, and stool specimens were prospectively included over a 16-week period. The isolates were recovered after aerobic, microaerophilic, and anaerobic incubation of clinical specimens on 5% sheep-blood, chocolate, Mueller-Hinton, trypticase soy, and MacConkey agar media (bioMérieux). After semi-automated Gram staining (Aerospray Wiescor; Elitech) and determination of catalase and oxidase activities, isolates were inoculated into the appropriate Vitek identification strip using the Vitek 2 apparatus (bioMérieux) or API ANA identification strip for anaerobes (bioMérieux). In parallel, 1 single colony was directly deposited on a MALDI-TOF MTP 384 target plate (Bruker Daltonik GmbH), and 4 such deposits were made for each isolate. The preparation was overlaid with 2 mL of matrix solution (saturated solution of a-cyano-4-hydroxycinnamic acid in 50% acetonitrile, and 2.5% tri-fluoracetic-acid). A total of 15 isolates ( spots) were deposited per plate, and the matrix-sample 4 ϫ 15 was crystallized by air-drying at room temperature for 5 minutes.
Mass spectrometry. Measurements were performed with an Autoflex II mass spectrometer (Bruker Daltonik) equipped with a 337-nm nitrogen laser. Spectra were recorded in the positive linear mode (delay, 170 ns; ion source 1 voltage, 20 kV; ion source 2 voltage, 18.5 kV; lens voltage, 7 kV; mass range, 2-20 kDa). Each spectrum was obtained after 675 shots in automatic mode at a variable laser power, and the acquisition time ranged from 30 to 60 s per spot. Data were automatically acquired using AutoXecute acquisition control software. The 2 first raw spectra obtained for each isolate were imported into BioTyper software, version 2.0 (Bruker Daltonik GmbH), and were analyzed by standard pattern matching (with default parameter settings) against the spectra of 2881 species used as reference database in the BioTyper database (these spectra are an integrated part of the BioTyper software version, as updated in June 2008). When both spots yielded score у1.9, the analysis stopped. When 1 or both spots yielded score !1.9, the MALDI-TOF mass spectrometry read the 2 other spots. The method of identification included the m/z from 3 to 15 kDa. For each spectrum, no more than 100 peaks were taken into account and compared with peaks in the database. The 15 bacterial species exhibiting the most similar peptidic pattern with the isolate were ranked by their identification score. Criteria for identification of isolates. Accurate identification of isolates using the Vitek system was confirmed when the index T was у0.25; identification using the API system was confirmed when the percentage of identification was у90% and the index T was у0.25. As for MALDI-TOF analysis, we used modified score values proposed by the manufacturer: (1) a score у1.9 indicated species identification, (2) a score of 1.7-1.9 indicated genus identification, and (3) a score !1.7 indicated no identification. An isolate was considered correctly identified by MALDI-TOF mass spectrometry if у2 of 4 spectra had a score у1.9 for species identification or у1.7 for genus identification. For isolates discrepantly identified by routine phenotype analysis and MALDI-TOF mass spectrometry, we performed partial 16S ribosomal RNA (rRNA) or rpoB gene sequencing, as described elsewhere [8] [9] [10] . An isolate was correctly identified when its almost full-length 16S rRNA gene sequence yielded у98.7% sequence similarity with the closest bacterial species sequence in GenBank [11] ; it was correctly identified when its partial rpoB gene sequence yielded у97% sequence similarity with the closest bacterial species sequence in GenBank or a local database [10, 12] .
MALDI-TOF delay and cost analysis. We defined MALDI-TOF mass spectrometry identification delay as the delay between the deposit of bacteria on the MALDI-TOF plate by the technician and the end of the informatics interpretation of spectra (ie, identification ready to be transmitted to the clinician). This delay was randomly measured in 10 nonconsecutive days. Costs of identification were measured by adding the cost of specific consumables, the cost for salary of personals, and the provisions for 5-year depreciation of the respective apparatus (Gram staining apparatus, microscope, identification apparatus, and mass spectrometer) on the basis of 20,000 isolates analyzed per year.
Statistical analyses. For bacterial species under study comprising у5 isolates tested by MALDI-TOF mass spectrometry, we tested the correlation between the precision of MALDI-TOF mass spectrometry identification (185% of isolates identified at the species level-that is, with a MALDI-TOF mass spectrometry identification score у1.9) and the number of reference spectra for that bacterial species in the BioTyper database using a Mantel-Haenszel test.
RESULTS

Concordant MALDI-TOF mass spectrometry identification.
Of 1660 isolates prospectively analyzed over a 16-week period, 260 isolates (15.7%) did not yield an accurate identification after reading of 2 spots because 1 or both spots were either empty or too small to allow any analysis (Table 1) . For these 260 isolates, a peptidic profile was then gathered after reading the 2 further spots. Of 1660 isolates (including 45 genera and 109 species, with 1-347 isolates per species), 1586 (95.5%) yielded identical identifications by current methods of identification and MALDI-TOF mass spectrometry. Of these isolates, 1397 (84.1%) yielded the same species identification by MALDI-TOF mass spectrometry and routine tests, and 189 (11.3%) yielded the same genus identification by MALDI-TOF mass spectrometry and routine tests. Isolates identified at the genus level comprised 2 (100%) of 2 Actinomyces species, 2 (6.7%) of 30 Bacteroides species, 1 (7.1%) of 14 Citrobacter species, 7 (46.7%) of 15 Corynebacterium species, 1 (1.4%) of 72 Enterobacter species, 13 (15.5%) of 84 Enterococcus species, 2 (1%) of 206 Escherichia coli, 1 (20%) of 5 Fusobacterium species, 2 (28.6%) of 7 Haemophilus species, 1 (50%) of 2 Kingella kingae, 2 (1.9%) of 104 Klebsiella species, 1 (50%) of 2 Lactobacillus species, 2 (66.7%) of 3 Micrococcus luteus iso- Table 2 ). When the spectra of the aforementioned isolates were added to the Bruker database, further identification was accurate.
Phenotype erroneous identifications. The current methods of identification failed for 32 isolates (1.9%), which were all anaerobes ( Table 2 ). Phenotypic identification was erroneous for 28 isolates (1.7%). One isolate phenotypically identified as Streptococcus mitis was identified as Actinomyces species by MALDI-TOF mass spectrometry and was confirmed to be Actinomyces naeslundii by 16S rRNA gene sequencing. One isolate phenotypically identified as Aerococcus viridans was identified as S. parasanguinis by MALDI-TOF mass spectrometry and as S. infantis by partial rpoB gene sequencing. One isolate phenotypically identified as Gemella morbilorum was identified as Streptococcus species by MALDI-TOF mass spectrometry and was confirmed to be Streptococcus sanguinis by partial rpoB gene sequencing. One Corynebacterium group G isolate was identified as Lactobacillus species by MALDI-TOF mass spectrometry and was confirmed to be Lactobacillus zeae by 16S rRNA gene sequencing. One isolate phenotypically identified as Staphylococcus epidermidis was identified as Propionibacterium species by MALDI-TOF mass spectrometry and as S. epidermidis by rpoB sequencing.
MALDI-TOF mass spectrometry identification performances. For bacterial species comprising у5 isolates under study, the fact that у85% of isolates were identified to the species level by MALDI-TOF mass spectrometry analysis was borderline correlated with the fact that the reference database for that species comprised 15 reference spectra ( ). Accurate MALDI-P p .45 TOF mass spectrometry identification was significantly correlated with the fact that the reference database for those species included у10 reference spectra ( ). P p .01 Comparative delay and cost of MALDI-TOF mass spectrometry identification. The delay for MALDI-TOF mass spectrometry identification (15 isolates; 4 spots per isolate) was 90 minutes, including 25 minutes for plate preparation, 15 minutes for plate loading, and 50 minutes for plate reading and spectra interpretation, for a mean delay of 6 minutes per isolate (Figure 2) . Furthermore, use of only 2 spots per isolate resulted in a delay of identification of 55 minutes for 15 colonies and a mean delay of 3.5 minutes per isolate. Because our protocol includes a 5-minute matrix drying step regardless of the number of isolates, the minimum delay for MALDI-TOF mass spectrometry identification of 1 isolate would be 8.5 minutes, including 7 minutes for colony and matrix deposition and drying, a 0.5-minute spectra acquisition, and 1 minute for informatics interpretation and identification of spectra. The cost for 1 MALDI-TOF mass spectrometry identification as tabulated in this laboratory is presented in Table 3 .
DISCUSSION
We tested a large collection of bacteria by mass spectrometry for the first time in a routine laboratory. The proof-of-concept that mass spectrometry could identify crude bacteria was established 130 years ago [2] , but the pioneering works were published in nonmedical, specialized mass spectrometry journals [2, 4, 5] . Such studies dealt with anaerobic bacteria from the oral flora [13] ; clostridia [8] ; Enterobacteriaceae [14] , including E. coli [15, 16] , Yersinia enterocolitica [16] , and Erwinia species [17] ; nonfermenting bacteria [18] , such as Burkholderia cepacia complex [19] ; Haemophilus species [20] ; various grampositive cocci [21] , including Staphylococcus species [7] , viridans Streptococcus species [22] , Listeria species [23] , and Vagococcus fluvialis [24] ; and Mycobacterium species [25] [26] [27] . MALDI-TOF mass spectrometry was also used to discriminate antibiotic resistance within minutes (Table 2) ; for example, methicillin-resistant S. aureus was identified [28] [29] [30] [31] [32] [33] because the spectra of methicillin-resistant and methicillin-susceptible S. aureus organisms differed in the mass range of m/z 500-3500 Da [29, 30] , and spectral profiles were accurately clustered into 2 separate groups (ie, methicillin-resistant and methicillinsusceptible S. aureus) [30] . Camara et al [34] demonstrated the usefulness of MALDI-TOF mass spectrometry for rapid discrimination of ampicillin-resistant E. coli organisms displaying an m/z 29,000 peak that has been confirmed to be a b-lactamase. Antibiotic resistance-associated specific peak detection depended on the type of culture medium, instruments, and experimental protocols [32, 33] , suggesting that local databases should be built for accurate detection of resistance profiles. MALDI-TOF mass spectrometry further discriminated bacteria at the subspecies level (Francisella tularensis [35] and Bartonella subspecies; P. E. Fournier, unpublished data), at the serotype level (Salmonella species), and at the strain level (Helicobacter pylori [36, 37] , Haemophilus influenzae [38] and Bartonella henselae; P. E. Fournier, unpublished data). Also, MALDI-TOF mass spectrometry analyses proved to be effective for the identification of bacterial isolates generated from specimens collected in selected clinical situations (eg, respiratory tract specimens obtained from patients with cystic fibrosis) [6] . Bacterial isolates (E. coli) tested using the same reagents in different laboratories with different mass spectrometers have also yielded reproducible, identifying spectra [39] .
We observed that 95.4% of isolates were identified by MALDI-TOF mass spectrometry at the species and genus levels. With the exception of F. nucleatum, the lack of MALDI-TOF mass spectrometry identification was observed almost only for non-Clostridium anaerobes, which had no reference in the Bruker database. In fact, when based on accurate databases, MALDI-TOF mass spectrometry will be of particular interest for the identification of anaerobes. As illustrated in this report, these fastidious organisms are poorly identified by current phenotypic methods, which lack specificity and result in ambiguous or even erroneous identification. The availability of easy and rapid MALDI-TOF mass spectrometry identification of anaerobes may encourage microbiologists to further isolate and culture this group of pathogens, the presence of which is often underestimated in situations such as orthopedic prosthesis infections [40] or brain abscess [41] . Likewise, the misidentification of all S. sonnei organisms as E. coli was due to an absence in the database. This was also the case for almost one-half of S. pneumoniae isolates that were misidentified as S. parasanguinis (a closely related species within the mitis group of Streptococcus species [42] ), because the database included only 3 S. pneumoniae and 2 S. parasanguinis reference spectra. The incorporation of additional S. pneumoniae spectra solved this problem. Likewise, 7 S. maltophilia isolates were misidentified as P. hibiscicola by MALDI-TOF mass spectrometry. We hypothesized that this discordance resulted from a trivial mislabeling of bacterial species in the Bruker database. Indeed, P. hibiscicola is an invalid name for a nonfermenting gram-negative rod that was demonstrated to be S. maltophilia [43] [44] [45] . Addition of correct spectra in the database solved these problems. Approximately 16% of isolates were identified only at the genus level by MALDI-TOF mass spectrometry analysis; an example of this identification was provided by P. acnes, for which only 1 spectrum (DSM 1897 strain) was included in the Bruker database. We hypothesized that this unique spectrum may not be representative of the true diversity of P. acnes profiles, and the inclusion of additional P. acnes spectra in the database resulted in a 100% correct identification (data not shown). The same remark held true for Bacillus cereus, for which the Bruker database also included only 1 reference spectrum. We further observed that the statistical significance of the correlation between precision in MALDI-TOF mass spectrometry identification and the number of reference spectra increased from у5 reference spectra to у10 reference spectra in the database, further indicating that a complete and representative database is, unsurprisingly, a critical requirement for the accurate identification of isolates by MALDI-TOF mass spectrometry [46] . This large, prospective study included 11600 isolates, representative of 1100 bacterial species, which were analyzed regardless of the source of isolation and bacterial phylum. We used a very simple experimental protocol that involved directly depositing bacterial colonies onto the MALDI-TOF mass spectrometry plate, regardless of the agar-based medium, without any subculture or colony preparation. The direct protocol used in this study mostly suppressed manipulations of organisms and enabled their identification with little delay. The very basic procedure that we used contrasts with some studies in which identification has been performed after subculture onto selective medium [27] or extensive manipulation of colonies [13, 27, 45] after inactivation of the organisms [8, 18] . Studies that also used direct analysis of bacterial colonies found a delay for identification of less than 10 minutes due to the !1-minute delay for spectrum acquisition [4, 45] . Use of such a simple protocol helped to train technicians in р1 hour. In our laboratory, bacteria are typically deposited onto MALDI-TOF mass spectrometry plates at 7:00-7:30 am, and all identifications are available for the clinician at 9:30 am. Moreover, on-going improvement in the quality of spotting allowed decreasing the number of spot from 4 to 2 per isolate without alteration of the performances. In our institution, this timing greatly contributes to the clinical management of patients, because most medical decisions, including adaptation of antibiotic regimens, ordering of additional tests, and the prevention of nosocomial infections, are made before 1 pm. We calculated that MALDI-TOF mass spectrometry identification costs 22%-32% of the cost of conventional phenotypic identification. We did not observe any discrepancies between MALDI-TOF mass spectrometry and Gram staining, suggesting that MALDI-TOF mass spectrometry could be used as a first-line technique without prior Gram staining. We propose that Gram staining could be used only for isolates exhibiting a MALDI-TOF mass spectrometry score р1.9 and for both unusual isolates and isolates obtained from unusual clinical sites.
The data prospectively gathered in the present study demonstrated that MALDI-TOF mass spectrometry identification is an efficient, cost-effective method for the rapid and routine identification of bacterial isolates in the clinical microbiology laboratory. It can be used as the first-line method of identification, before Gram staining and any biochemical profiling, when using a database that includes у10 reference spectra per bacterial species and an identification score р1.9. The cost of analysis will decrease as bench-top instruments are used more often. The potential for a identification at the serotype or strain level, and antibiotic resistance profiling within minutes make MALDI-TOF mass spectrometry an on-going revolution in the clinical microbiology laboratory. It will significantly change business models as the diagnostic industry may develop new models to sell, and the cost of reagents will be very low.
